Efficacy and safety of denosumab therapy for low bone mineral density in childhood cancer survivors: A report of preliminary experience.
Ting-Huan HuangHsi-Che LiuJen-Yin HouChing-Yi ChangFang-Ju SunTing-Chi YehPublished in: Pediatric blood & cancer (2019)
Denosumab is an effective treatment for low BMD in childhood cancer survivors. However, the complication of hypocalcemia might develop posttreatment.